CPT 72197Radiology

Mri pelvis w/o & w/dye

CPT 72197 is the billing code for an MRI scan of the pelvis performed twice—once without contrast dye and again after contrast dye is injected into a vein. This provides radiologists with enhanced visualization of pelvic organs, blood vessels, and soft tissues to detect abnormalities like tumors, infections, or structural problems.

Showing rates for

National Average

Base Medicare rate

$331.23

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

2.2

PE RVU (NF)

7.89

MP RVU

0.15

Total RVU

10.24

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Verify medical necessity documentation explicitly supports the need for BOTH non-contrast AND contrast imaging sequences, not just one or the other
Impact: Prevents denials and downcoding to 72195 (without contrast) or 72196 (with contrast only), which could reduce reimbursement by $50-80 per case
Document contrast type, dosage, route of administration, and lack of contraindications in the medical record to support the dual-phase protocol
Impact: Reduces denial rate by 30-40% and strengthens appeal success when medical necessity is questioned
Ensure ordering physician documentation clearly states the clinical indication and why single-phase imaging is insufficient for diagnosis
Impact: Critical for medical necessity validation; inadequate indication is the #1 denial reason, affecting 25-35% of claims
Bill facility and professional components separately using modifiers TC and 26 when services are split between different entities
Impact: Ensures proper payment allocation; prevents overpayment recovery audits and maintains compliance with split-billing regulations
Verify patient renal function (GFR/creatinine) is documented before contrast administration, especially for patients over 60 or with diabetes/hypertension
Impact: Required for compliance and risk management; missing documentation can trigger quality audits even if claim is paid
Use diagnosis codes that clearly support the need for advanced MRI imaging rather than less expensive modalities like ultrasound or non-contrast CT
Impact: Improves first-pass approval rate by 20-30%; codes should reflect suspected malignancy, staging, or complex pathology

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 72197?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 72197 in 2025?

The 2025 Medicare national average reimbursement rate for CPT 72197 is $331.23 for both facility and non-facility settings. This rate is based on 10.24 total RVUs (2.2 work RVU, 7.89 practice expense RVU, and 0.15 malpractice RVU) multiplied by the 2025 conversion factor of 32.3465. Actual payment may vary based on geographic location and local Medicare Administrative Contractor adjustments.

What is the difference between CPT 72197 and 72196?

CPT 72197 includes MRI imaging both without and with contrast material, requiring two separate imaging sequences. CPT 72196 describes MRI pelvis with contrast material only, without the initial non-contrast sequences. Code 72197 is appropriate when the clinical question requires comparison of pre- and post-contrast images for lesion characterization, tumor staging, or vascular assessment. Using 72197 requires documentation supporting the medical necessity of both imaging phases.

Does CPT 72197 require prior authorization from Medicare or commercial payers?

Medicare Advantage plans frequently require prior authorization for CPT 72197, though Original Medicare typically does not mandate pre-authorization. Most commercial payers require prior authorization or pre-certification for advanced imaging including MRI with contrast. Many payers now use radiology benefits managers (RBMs) that require clinical decision support through portals before authorization. Always verify specific payer requirements before scheduling, as performing the service without required authorization often results in denial or patient financial responsibility.

Can I bill CPT 72197 with an MRI of the abdomen on the same day?

Yes, CPT 72197 can be billed with abdominal MRI codes (such as 74183) on the same day when both exams are medically necessary and address different clinical questions. Modifier 59 or XU may be required to indicate distinct anatomical sites and prevent bundling. Documentation must clearly establish separate medical necessity for each body region. Some payers have specific policies limiting same-day MRI studies, so verify coverage policies and ensure each exam addresses a unique diagnostic question not answerable by a single extended field-of-view study.

What diagnosis codes support medical necessity for CPT 72197?

Diagnosis codes supporting CPT 72197 typically include suspected or known pelvic malignancies (C53-C57, C61, C67, C20), endometriosis (N80.x), complex ovarian masses (N83.2), pelvic inflammatory disease (N73.x), staging of rectal or bladder cancer, unexplained pelvic pain with suspected structural abnormality, and evaluation of pelvic masses inadequately characterized by other imaging. The diagnosis must justify why dual-phase contrast imaging is necessary rather than single-phase MRI or alternative modalities. Payer LCD/NCD policies often specify covered indications, so consult local coverage determinations.

How many RVUs is CPT code 72197 worth in 2025?

CPT 72197 has a total of 10.24 RVUs in 2025, comprised of 2.2 work RVUs, 7.89 practice expense RVUs (non-facility), 7.89 practice expense RVUs (facility), and 0.15 malpractice RVUs. The relatively high total RVU value reflects the technical complexity, equipment costs, contrast materials, and professional interpretation time required for dual-phase pelvic MRI imaging. This RVU value ranks 72197 among the higher-valued diagnostic radiology procedures.

What contrast agents are typically used for CPT 72197 and how does this affect billing?

Gadolinium-based contrast agents (GBCAs) are standard for MRI procedures coded with 72197. Common agents include gadobutrol, gadoterate, and gadoteridol. The contrast agent cost is included in the technical component reimbursement and should not be billed separately with a HCPCS code when billing 72197. Documentation must include the specific agent name, dose, and administration route. For patients with severe renal impairment (GFR <30), alternative non-contrast protocols may be necessary, which would require different CPT coding (72195). The choice of contrast agent does not change the CPT code or reimbursement amount.